X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1960) 1960
Book Review (116) 116
Publication (70) 70
Magazine Article (5) 5
Book Chapter (3) 3
Web Resource (2) 2
Dissertation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1786) 1786
humans (1588) 1588
cefazolin - therapeutic use (1317) 1317
female (1024) 1024
male (936) 936
middle aged (697) 697
anti-bacterial agents - therapeutic use (682) 682
adult (640) 640
cefazolin (527) 527
aged (522) 522
surgical wound infection - prevention & control (382) 382
surgery (359) 359
abridged index medicus (355) 355
cefazolin - administration & dosage (347) 347
cephalosporins - therapeutic use (322) 322
antibiotics (318) 318
animals (284) 284
prospective studies (261) 261
antibiotic prophylaxis (253) 253
adolescent (221) 221
pharmacology & pharmacy (209) 209
treatment outcome (207) 207
retrospective studies (202) 202
anti-bacterial agents - administration & dosage (196) 196
premedication (188) 188
staphylococcal infections - drug therapy (187) 187
microbial sensitivity tests (178) 178
infectious diseases (176) 176
aged, 80 and over (175) 175
drug therapy, combination (164) 164
risk factors (162) 162
infections (161) 161
microbiology (158) 158
gentamicins - therapeutic use (147) 147
vancomycin - therapeutic use (146) 146
cefazolin - pharmacology (145) 145
double-blind method (145) 145
health aspects (145) 145
child (133) 133
time factors (133) 133
postoperative complications - prevention & control (131) 131
infection (128) 128
ophthalmology (128) 128
vancomycin (127) 127
clinical trials as topic (121) 121
bacterial infections - drug therapy (117) 117
bacterial infections - prevention & control (115) 115
cefazolin - adverse effects (114) 114
prevention (107) 107
staphylococcus aureus - drug effects (105) 105
random allocation (103) 103
pregnancy (100) 100
staphylococcus aureus (98) 98
orthopedics (97) 97
prophylaxis (97) 97
staphylococcal infections - microbiology (97) 97
anti-bacterial agents - pharmacology (95) 95
antibiotic prophylaxis - methods (94) 94
cefazolin - pharmacokinetics (93) 93
cephalosporins (91) 91
analysis (90) 90
drug administration schedule (90) 90
injections, intravenous (88) 88
eye infections, bacterial - drug therapy (87) 87
child, preschool (86) 86
pharmacokinetics (83) 83
drug therapy, combination - therapeutic use (82) 82
antibiotic-prophylaxis (81) 81
medicine, general & internal (80) 80
surgical wound infection - epidemiology (80) 80
urology & nephrology (80) 80
cefazolin - blood (78) 78
ampicillin - therapeutic use (77) 77
peritonitis - drug therapy (76) 76
therapy (75) 75
young adult (75) 75
risk (74) 74
staphylococcal infections - prevention & control (74) 74
infant (73) 73
medicine & public health (73) 73
rabbits (72) 72
tobramycin - therapeutic use (70) 70
cephalosporins - administration & dosage (67) 67
management (67) 67
rats (67) 67
anti-bacterial agents - adverse effects (65) 65
antimicrobial prophylaxis (65) 65
corneal ulcer - drug therapy (65) 65
surgical wound infection - microbiology (65) 65
follow-up studies (63) 63
staphylococcus aureus - isolation & purification (62) 62
complications (60) 60
mice (60) 60
anti-bacterial agents - pharmacokinetics (59) 59
cefazolin - metabolism (59) 59
drug resistance, microbial (59) 59
incidence (59) 59
obstetrics & gynecology (59) 59
penicillins - therapeutic use (59) 59
bacteremia (58) 58
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1747) 1747
Japanese (49) 49
French (40) 40
German (37) 37
Russian (25) 25
Italian (21) 21
Spanish (19) 19
Chinese (8) 8
Bulgarian (6) 6
Portuguese (5) 5
Czech (3) 3
Hebrew (2) 2
Polish (2) 2
Danish (1) 1
Hungarian (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37281 - e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Index Medicus | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Trials, ISSN 1745-6215, 2016, Volume 17, Issue 1, pp. 170 - 170
Background: Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 20-50 % 90 day mortality. The limitations of... 
Flucloxacillin | Cefazolin | Methicillin-resistant | Combination | Daptomycin | MRSA | Randomised controlled trial | Vancomycin | Cloxacillin | Staphylococcus aureus | Nafcillin | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | ACUTE KIDNEY INJURY | VITRO PHARMACOKINETIC/PHARMACODYNAMIC MODEL | PIPERACILLIN-TAZOBACTAM | INTRAVENOUS-DRUG-USERS | EMPIRICAL-THERAPY | IN-VITRO | ANTIBACTERIAL ACTIVITY | PLUS CEFTAROLINE | BETA-LACTAMS | Singapore | Humans | Clinical Protocols | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Time Factors | Anti-Bacterial Agents - adverse effects | Staphylococcal Infections - microbiology | Drug Therapy, Combination | Methicillin Resistance | Cloxacillin - therapeutic use | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Treatment Outcome | Floxacillin - therapeutic use | New Zealand | Staphylococcal Infections - diagnosis | Vancomycin - therapeutic use | beta-Lactams - adverse effects | Israel | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Australia | beta-Lactams - therapeutic use | Research Design | Prevention | Drug resistance in microorganisms | Care and treatment | Analysis | Staphylococcus aureus infections | Clinical trials | Development and progression | Beta lactamases | Research | Health aspects | Index Medicus
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 06/2015, Volume 313, Issue 21, pp. 2162 - 2171
Journal Article
JAMA Surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 432 - 439
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2011, Volume 69, Issue 8, pp. 2106 - 2111
Purpose In 2009, the American Academy Of Orthopedic Surgeons recommended lifelong prophylaxis after orthopedic total joint replacement (TJR) before these... 
Surgery | KNEE REPLACEMENT | BACTEREMIA | DENTISTRY, ORAL SURGERY & MEDICINE | ARTHROPLASTY | DENTAL TREATMENT | INFECTION | ENDOCARDITIS | PROSTHETIC JOINTS | HIP | Staphylococcus epidermidis - physiology | Antibiotic Prophylaxis - statistics & numerical data | Disinfection - statistics & numerical data | Humans | Joint Prosthesis - statistics & numerical data | Peroxides - therapeutic use | Pseudomonas aeruginosa - physiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Povidone-Iodine - therapeutic use | Retrospective Studies | Temporomandibular Joint - surgery | Surgical Wound Infection - epidemiology | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Penicillins - therapeutic use | Peptostreptococcus - physiology | Arthroplasty, Replacement - statistics & numerical data | Bacitracin - therapeutic use | Clindamycin - therapeutic use | Gram-Positive Bacterial Infections - epidemiology | Practice Patterns, Dentists' - statistics & numerical data | Biofilms | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Device Removal - statistics & numerical data | Vancomycin - therapeutic use | Practice Guidelines as Topic | Therapeutic Irrigation | Surveys | Usage | Joint replacement | Antibiotics | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2386 - 2391
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SURGERY | REPLACEMENT | TOTAL HIP-ARTHROPLASTY | BLIND RANDOMIZED TRIAL | IMPACT | VANCOMYCIN | THERAPY | KNEE ARTHROPLASTY | PREVENTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CEFAZOLIN | Joint Prosthesis - microbiology | Glycopeptides - administration & dosage | Humans | Drug Resistance, Bacterial | Male | Antibiotic Prophylaxis | Enterococcus - physiology | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - microbiology | Female | Retrospective Studies | Gram-Negative Bacteria - physiology | Methicillin-Resistant Staphylococcus aureus - physiology | Prosthesis-Related Infections - epidemiology | Cefazolin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Arthroplasty | Cefazolin - administration & dosage | Australia - epidemiology | Knee - microbiology | Glycopeptides - therapeutic use | Gram-Negative Bacteria - drug effects | Prosthesis-Related Infections - prevention & control | Knee - surgery | Aged | Enterococcus - drug effects | Hip - surgery | Hip - microbiology | Anti-Bacterial Agents - administration & dosage | Practice Guidelines as Topic | Index Medicus | Pathogens | Prophylaxis | Drug resistance | Joint diseases | Epidemiology | Infection | Gram-negative bacilli | Microorganisms | Cefazolin | Hospitals | Antibiotics | Etiology | Glycopeptides | Prosthetics | Epidemiology and Surveillance
Journal Article